Streetbeat News

Stock Prices

MRK

Merck & Co (NYSE:MRK) reported Q4 earnings of $0.03 per share, surpassing the $(0.11) estimate, a 98.15% decrease from last year's $1.62. Sales reached $14.63B, beating the $14.50B estimate, marking a 5.78% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 11:31 am

TECH

Bio-Techne (NASDAQ:TECH) reported Q2 adjusted EPS of $0.40, missing the consensus estimate of $0.41, and sales of $272.60M, missing the estimate of $277.53M. This represents a 14.89% decrease in EPS and a 0.37% increase in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 11:31 am

BDX

BD (Becton, Dickinson and Company) has announced an increase in its financial guidance for the fiscal year 2024, signaling stronger performance expectations.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 11:31 am

BDX

Becton, Dickinson (BDX) reported Q1 2024 adjusted EPS of $2.68, surpassing the $2.40 estimate, but its sales of $4.71B fell short of the $4.73B estimate, marking a 2.62% year-over-year increase.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 11:30 am

AUVI

Applied UV, Inc (NASDAQ:AUVI) announced its involvement in the Larimar City & Resort project in the Dominican Republic, developing case goods and smart building technologies. The company expects to deliver prototypes in Q3 2024, with a potential revenue opportunity of $250 to $300 million over 3-6 years. AUVI shares rose 1.89% in premarket trading.

Portfolio Pulse from Anusuya Lahiri

February 01, 2024 | 11:30 am

NNVC

NanoViricides, Inc. has announced that its NV-COV-2 oral drug products have shown strong safety and tolerability in demonstrations, which could have implications beyond treating COVID-19. This development could potentially expand the application of NV-COV-2 to other diseases and conditions, marking a significant milestone for the company.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 11:26 am

BC

Brunswick Corporation projects Q1 2024 net sales to be between $1.3B-$1.4B, significantly lower than the estimated $1.64B. Additionally, the company forecasts its FY24 adjusted diluted EPS to be $1.30-$1.40, well below the estimated $2.22.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 11:24 am

SHEL

Shell PLC (NYSE:SHEL) shares rose in premarket trading after reporting Q4 FY23 results. Despite missing revenue expectations with $78.73 billion against a consensus of $84.71 billion, adjusted earnings per ADS were $2.22, surpassing the consensus of $0.97. Net income significantly dropped to $474 million from $10.41 billion a year ago. The company announced a new $3.5 billion share buyback program and raised its quarterly dividend by 4% to $0.344. FY24 capital expenditure is projected between $22 billion and $25 billion.

Portfolio Pulse from Lekha Gupta

February 01, 2024 | 11:24 am

BC

Brunswick Corporation projects its FY24 net sales to be between $6B-$6.2B, which is below the estimated $6.34B. Additionally, the company forecasts its FY24 adjusted diluted EPS to be in the range of $7-$8, also lower than the expected $8.67.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 11:22 am

BC

Brunswick (NYSE:BC) reported Q4 adjusted EPS of $1.45, missing the $1.65 estimate, and sales of $1.36B, below the $1.44B estimate. This represents a decrease in earnings by 27.14% and in sales by 13.96% compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 01, 2024 | 11:18 am